Levine said the organization is building on former investigation that demonstrates the safety and success with the drug. "That gives us lots of hope that most likely in a number of years' time we could deliver this by means of regulatory acceptance and hopefully to sufferers who actually need it."Mel was considered one of 7 (from twelve) who was vi